The LTC Innovation Blog

Long-term care pharmacies are heading into one of the most significant reimbursement shifts in years. With the first set of medications entering the Medicare Drug Price Negotiation Program on January 1, 2026, LTC pharmacies must prepare now for the operational, financial, and clinical ripple effects that come with the introduction of the Maximum Fair Price (MFP) reimbursement framework.

Compliance is the foundation of safe, effective pharmacy operations in long-term care (LTC) settings. The regulatory landscape is complex, with strict oversight designed to protect patients and ensure proper medication management. Failure to comply can lead to severe consequences—fines, legal action, reputational damage, and (most importantly) harm to residents who rely on accurate and timely medication delivery.

Decoding the Decline in Reimbursements By Mark Fulton, PharmD, MBA, BCNSP, NSC-II